ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

ACAD 49.30 +1.74 (3.66%)
price chart
ACADIA Pharmaceuticals: Developing Late-Stage Assets With Blockbuster ...
ACADIA Pharmaceuticals (NASDAQ:ACAD) is a biopharmaceutical company focused on developing medications for diseases attacking the CNS (central nervous system).
Company Shares of ACADIA Pharmaceuticals Inc. Drops by -2.69%
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has dropped 2.69% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 16.27% in the last 4 weeks.
Stock in Motion: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares opened the most recent trading session at 48.07 and at the time of writing the last Bid was at 49.23.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Update
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has seen a shortfall of 268,925 shares or 1.9% in the short interest. The remaining shorts are 13.7% of the total floated shares.
Analyst Rating Update on ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) has received a hold rating for the short term, according to the rank of 3 from research firm, Zacks.
Analyst Price Target Update on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)  American Trade Journal
Commit To Buy Acadia Pharmaceuticals At $32, Earn 13.8% Using Options  Nasdaq
HC Wainwright Maintains Buy on ACADIA Pharmaceuticals Inc. Following Meeting ...
In a research report issued yesterday, H.C. Wainwright analyst Andrew Fein maintained a Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a $50 price target, after having a meeting with management last week. Fein noted, “The main ...
ACADIA Pharmaceuticals's "Buy" Rating Reaffirmed at HC ...  Dakota Financial News
ACADIA Pharmaceuticals Rating Reiterated by HC Wainright (ACAD)  The Legacy
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Analyst Rating Update
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) has received a hold rating for the short term, according to the rank of 3 from research firm, Zacks.
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) in Focus  Street Report
3 Biotech Stocks Are Just So Hot Right Now - ACADIA Pharmaceuticals (NASDAQ ...  Wall Street Observer
ACADIA Pharmaceuticals Inc., ARIAD Pharmaceuticals, Inc. Mobbed by Option Bulls
Biotech stocks have been red hot lately, and today is no exception. Two names within that sector seeing sizable upside this afternoon -- and attracting attention from option bulls -- are ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Ariad ...
Company Shares of ACADIA Pharmaceuticals Inc. Drops by -0.57%
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has lost 0.57% during the past week and dropped 1.11% in the last 4 weeks. The shares have outperformed the S&P 500 by 0.61% in the past week but underperformed the index by 0.35% in the last 4 weeks.
Short Interest Update of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stated loss of 148,253 shares or 1.1% in the short interest. The short interest registered from 14,094,723 on June 15,2015 to 13,946,470 on June 30,2015.
Company Shares of ACADIA Pharmaceuticals Inc. Rally 5.4%  Insider Trading Report